K36 Therapeutics, Inc. Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics.
| K36 Therapeutics, Inc. Email Formats | Percentage |
| FLast@k36tx.com | 100% |
| First.Last@linktr.ee | 87% |
| FirstLast@linktr.ee | 8% |
| First@linktr.ee | 3% |
| FirstL@linktr.ee | 2% |
Biotechnology ResearchMassachusetts, United States11-50 Employees
Translating epigenetic modulation of oncogenic pathways into first-in-class small molecule therapeutics.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.